Literature DB >> 2431392

The repressor sequence upstream of c-mos acts neither as polyadenylation site nor as transcription termination region.

F A van der Hoorn, B Neupert.   

Abstract

Recently we reported that the c-mos(rat) coding region is preceded by sequences (RIS) which repress accumulation of c-mos RNA in the cytoplasm. To investigate the effect of RIS on RNA transcription or processing a retroviral promoter was inserted at different positions relative to RIS. Cotransfection was used to establish cell lines with high copy number of the plasmids and to avoid any selection for c-mos expression or RIS function. Analysis of RNA in the cell lines indicated that RIS does not provide a poly(A) site and allowed characterization of the c-mos(rat) poly(A) site. Surprisingly, RIS contains sequences homologous to elements involved in eucaryotic RNA cleavage/polyadenylation. To determine an effect of RIS on transcription, RNA was elongated in vitro in nuclei isolated from the cell lines and used to analyze the number of RNA polymerase II molecules transcribing different regions of the plasmid. The analysis showed that RIS does not act as transcription termination region.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2431392      PMCID: PMC311910          DOI: 10.1093/nar/14.22.8771

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  25 in total

1.  Complete nucleotide sequence of the Escherichia coli plasmid pBR322.

Authors:  J G Sutcliffe
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1979

2.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

3.  Inhibition of RNA cleavage but not polyadenylation by a point mutation in mRNA 3' consensus sequence AAUAAA.

Authors:  C Montell; E F Fisher; M H Caruthers; A J Berk
Journal:  Nature       Date:  1983 Oct 13-19       Impact factor: 49.962

4.  Two promoters of different strengths control the transcription of the mouse alpha-amylase gene Amy-1a in the parotid gland and the liver.

Authors:  U Schibler; O Hagenbüchle; P K Wellauer; A C Pittet
Journal:  Cell       Date:  1983-06       Impact factor: 41.582

5.  Nucleotide sequence of the genome of a murine sarcoma virus.

Authors:  C Van Beveren; F van Straaten; J A Galleshaw; I M Verma
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

6.  Site-specific polyadenylation in a cell-free reaction.

Authors:  C L Moore; P A Sharp
Journal:  Cell       Date:  1984-03       Impact factor: 41.582

7.  Differential expression of cellular oncogenes during pre- and postnatal development of the mouse.

Authors:  R Müller; D J Slamon; J M Tremblay; M J Cline; I M Verma
Journal:  Nature       Date:  1982-10-14       Impact factor: 49.962

8.  Number and organization of actin-related sequences in the mouse genome.

Authors:  A J Minty; S Alonso; J L Guénet; M E Buckingham
Journal:  J Mol Biol       Date:  1983-06-15       Impact factor: 5.469

9.  Identification and molecular cloning of Moloney mouse sarcoma virus-specific sequences from uninfected mouse cells.

Authors:  M Jones; R A Bosselman; F A van der Hoorn; A Berns; H Fan; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

10.  Transcription unit of the rabbit beta 1 globin gene.

Authors:  M L Rohrbaugh; J E Johnson; M D James; R C Hardison
Journal:  Mol Cell Biol       Date:  1985-01       Impact factor: 4.272

View more
  3 in total

1.  Identification of a cis acting element responsible for muscle specific expression of the c-mos protooncogene.

Authors:  J L Lenormand; M Guillier; S A Leibovitch
Journal:  Nucleic Acids Res       Date:  1993-02-11       Impact factor: 16.971

Review 2.  Cancer genes generated by rare chromosomal rearrangements rather than activation of oncogenes.

Authors:  P H Duesberg
Journal:  Med Oncol Tumor Pharmacother       Date:  1987

Review 3.  Cancer genes: rare recombinants instead of activated oncogenes (a review).

Authors:  P H Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.